Nortis is developing the next generation of in-vitro
systems that will allow scientists to better understand the causes of
human disease. These systems represent urgently-awaited alternatives to
animal testing, promising to drastically accelerate the discovery of
new therapeutic drugs and the evaluation of toxic substances.
Nortis’ in-vitro systems are based on small segments
of tissues and organs grown from human-derived cells in disposable
chip-like devices. This makes testing compounds faster, cheaper,
and—most importantly—more predictive than animal testing. We anticipate
that Nortis’ tissue-engineered in-vitro systems will become essential
tools for finding cures for the most debilitating diseases of our time.